Exact Basilar Artery Occlusion Location Indicates Stroke Etiology and Recanalization Success in Patients Eligible for Endovascular Stroke Treatment.


Journal

Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 23 06 2022
accepted: 25 10 2022
medline: 29 5 2023
pubmed: 3 12 2022
entrez: 2 12 2022
Statut: ppublish

Résumé

Endovascular stroke treatment (EST) is commonly performed for acute basilar artery occlusion (BAO). We aimed to identify the role of the exact location of BAO in patients receiving EST regarding the stroke etiology, recanalization success and prediction of favorable clinical outcome. Retrospective analysis of 191 consecutive patients treated for BAO with EST from 01/2013 until 06/2021 in a tertiary stroke center. Groups were defined according to exact location of BAO in I: proximal third, II: middle third, III: distal third and IV: tip of the basilar artery. Univariate and multivariate analyses were performed for BAO location comparing stroke etiology, recanalization result and favorable clinical outcome according to mRS 0-3 90 days after stroke onset. Occlusion sides types I-IV were evenly distributed (37, 36, 60 and 58 patients). Types I and II were more often associated with large artery atherosclerosis (50 vs. 10 patients, p < 0.001). Distal/tip occlusion (types III/IV) occurred mostly in cardiac embolism or embolic stroke of unknown source (89 vs. 12 in types I/II, p < 0.001). Occlusion site correlated with the underlying stroke etiology (AUC [Area under the curve] 0.89, p < 0.0001, OR [odds ratio] for embolism in type IV: 245). Recanalization rates were higher in patients with distal occlusions (type III/IV OR 3.76, CI [95% confidence interval] 1.51-9.53, p = 0.0076). The BAO site is not predicting favorable clinical outcome. The exact basilar artery occlusion site in patients eligible for endovascular stroke treatment reflects the stroke etiology and is associated with differing recanalization success but does not predict favorable clinical outcome.

Identifiants

pubmed: 36459175
doi: 10.1007/s00062-022-01236-0
pii: 10.1007/s00062-022-01236-0
pmc: PMC10219858
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

483-490

Informations de copyright

© 2022. The Author(s).

Références

Clin Neuroradiol. 2021 Sep;31(3):745-752
pubmed: 32894352
Radiology. 2019 Jun;291(3):730-737
pubmed: 30912720
Lancet Neurol. 2009 Aug;8(8):724-30
pubmed: 19577962
J Neurointerv Surg. 2019 Dec;11(12):1174-1180
pubmed: 31239331
Aging Dis. 2021 Apr 1;12(2):404-414
pubmed: 33815873
World Neurosurg. 2021 Apr;148:e680-e688
pubmed: 33508493
Lancet Neurol. 2014 Apr;13(4):429-38
pubmed: 24646875
AJNR Am J Neuroradiol. 2017 Aug;38(8):1600-1604
pubmed: 28546252
AJNR Am J Neuroradiol. 2016 Nov;37(11):2072-2078
pubmed: 27313131
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Stroke. 2013 Sep;44(9):2650-63
pubmed: 23920012
Neurosurgery. 2020 Oct 15;87(5):982-991
pubmed: 32433730
Ann Clin Transl Neurol. 2018 Jan 30;5(3):357-368
pubmed: 29560380
Eur J Neurol. 2019 Feb;26(2):299-305
pubmed: 30218610
Lancet Neurol. 2020 Feb;19(2):115-122
pubmed: 31831388
AJNR Am J Neuroradiol. 2015 Oct;36(10):1947-52
pubmed: 26089317

Auteurs

Matthias A Mutke (MA)

Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Arne Potreck (A)

Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Niclas Schmitt (N)

Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Fatih Seker (F)

Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Peter A Ringleb (PA)

Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Simon Nagel (S)

Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Markus A Möhlenbruch (MA)

Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Martin Bendszus (M)

Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Charlotte S Weyland (CS)

Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Jessica Jesser (J)

Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. jessica.jesser@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH